Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 16901-16950 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06549114
Leniolisib for Immune Dysregulation in PIDs
PHASE2
Recruiting
12 participants
Started: Oct 21, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06370923
Harnessing Male Peer Networks to Enhance Engagement With HIV Prevention
NA
Recruiting
3,591 participants
Started: Oct 21, 2024 · Completed: May 31, 2028
1 condition
8 sponsors
1 location
NCT06730009
Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
PHASE1/PHASE2
Recruiting
42 participants
Started: Oct 21, 2024 · Completed: Aug 31, 2029
2 conditions
1 sponsor
1 location
NCT06481176
Blood Changes After Exercise in Restless Legs Syndrome
NA
Recruiting
30 participants
Started: Oct 21, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05821634
Personalizing Treatment Delivery
NA
Recruiting
81 participants
Started: Oct 21, 2024 · Completed: Apr 1, 2027
3 conditions
2 sponsors
1 location
NCT06666049
Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist
N/A
Recruiting
39 participants
Started: Oct 21, 2024 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06683950
Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment
PHASE4
Recruiting
40 participants
Started: Oct 21, 2024 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06631287
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
PHASE3
Recruiting
550 participants
Started: Oct 21, 2024 · Completed: Jul 1, 2027
4 conditions
3 sponsors
4 locations
NCT06649331
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
PHASE2
Recruiting
120 participants
Started: Oct 21, 2024 · Completed: Sep 30, 2027
5 conditions
1 sponsor
1 location
NCT06358157
The Ladera Large Bore Closure Feasibility Study
NA
Recruiting
30 participants
Started: Oct 21, 2024 · Completed: Oct 31, 2025
2 conditions
2 sponsors
3 locations
NCT06697470
Muscle and Subcutaneous Tissue Variation by Ultrasound and Impedance Linked to Fluid Balance in ICU Patients
N/A
Recruiting
40 participants
Started: Oct 21, 2024 · Completed: Nov 15, 2024
6 conditions
1 sponsor
2 locations
NCT06631339
Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)
NA
Recruiting
396 participants
Started: Oct 21, 2024 · Completed: Jan 26, 2027
5 conditions
2 sponsors
5 locations
NCT06430385
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
PHASE1/PHASE2
Recruiting
48 participants
Started: Oct 21, 2024 · Completed: Apr 30, 2030
1 condition
1 sponsor
6 locations
NCT06640582
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PHASE1/PHASE2
Recruiting
85 participants
Started: Oct 20, 2024 · Completed: Dec 28, 2026
7 conditions
1 sponsor
1 location
NCT06535776
Effects of Matrix Rhythm Therapy in Axial Spondyloarthritis Patients
NA
Recruiting
40 participants
Started: Oct 20, 2024 · Completed: Oct 5, 2025
2 conditions
1 sponsor
1 location
NCT06558682
Neoadjuvant Therapy in Cervical Cancer
NA
Recruiting
48 participants
Started: Oct 20, 2024 · Completed: Oct 1, 2026
1 condition
2 sponsors
1 location
NCT06645405
AI-Driven CTA Reconstruction for Intracranial LVO
NA
Recruiting
174 participants
Started: Oct 20, 2024 · Completed: Dec 31, 2025
4 conditions
1 sponsor
2 locations
NCT06642948
AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial
NA
Recruiting
80 participants
Started: Oct 20, 2024 · Completed: Jan 1, 2025
4 conditions
1 sponsor
1 location
NCT06554301
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
PHASE1
Recruiting
72 participants
Started: Oct 20, 2024 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT06257394
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
PHASE2
Recruiting
74 participants
Started: Oct 20, 2024 · Completed: Dec 31, 2034
1 condition
6 sponsors
6 locations
NCT06446401
"The Case of Triple Versus Double Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer"
N/A
Recruiting
1,400 participants
Started: Oct 20, 2024 · Completed: Dec 31, 2031
1 condition
12 sponsors
2 locations
NCT06633328
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
EARLY_PHASE1
Recruiting
30 participants
Started: Oct 20, 2024 · Completed: Oct 20, 2027
1 condition
2 sponsors
1 location
NCT06633341
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
EARLY_PHASE1
Recruiting
30 participants
Started: Oct 20, 2024 · Completed: Oct 20, 2027
1 condition
2 sponsors
1 location
NCT06633354
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
EARLY_PHASE1
Recruiting
30 participants
Started: Oct 20, 2024 · Completed: Oct 20, 2027
1 condition
2 sponsors
1 location
NCT06797765
Optical Coherence Tomography Angiography in Neurological Disease
N/A
Recruiting
50 participants
Started: Oct 20, 2024 · Completed: Oct 20, 2025
4 conditions
1 sponsor
1 location
NCT06861478
PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease
PHASE2
Recruiting
182 participants
Started: Oct 20, 2024 · Completed: Sep 20, 2026
1 condition
1 sponsor
1 location
NCT06508710
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
PHASE3
Recruiting
60 participants
Started: Oct 20, 2024 · Completed: Apr 30, 2026
1 condition
1 sponsor
4 locations
NCT06626139
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
PHASE2
Recruiting
120 participants
Started: Oct 20, 2024 · Completed: Nov 30, 2028
1 condition
1 sponsor
1 location
NCT06646250
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
N/A
Recruiting
180 participants
Started: Oct 20, 2024 · Completed: Dec 31, 2029
7 conditions
2 sponsors
1 location
NCT05439135
Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract
NA
Recruiting
62 participants
Started: Oct 20, 2024 · Completed: Oct 31, 2025
2 conditions
28 sponsors
1 location
NCT06228573
Transcranial Direct Current Stimulation and Yoga for Knee Osteoarthritis
NA
Recruiting
68 participants
Started: Oct 20, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT06653218
Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine
N/A
Recruiting
200 participants
Started: Oct 20, 2024 · Completed: Sep 30, 2025
2 conditions
3 sponsors
1 location
NCT06630780
Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma
NA
Recruiting
50 participants
Started: Oct 20, 2024 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT06655506
Enhanced Recovery Protocols in Gynecologic Oncology
N/A
Recruiting
600 participants
Started: Oct 20, 2024 · Completed: Jul 30, 2026
6 conditions
5 sponsors
8 locations
NCT06636266
Examining Scottish Chiropractic Professional Identity Using Chiropractic Professional Identity Scales
N/A
Recruiting
78 participants
Started: Oct 20, 2024 · Completed: May 30, 2025
1 condition
1 sponsor
1 location
NCT06653868
Grafting of the Peri-implant Bony Defects Around Immediate Implants Using Xenogenic Versus Alloplastic Sticky Grafts: Randomized Controlled Clinical Trial
NA
Recruiting
20 participants
Started: Oct 20, 2024 · Completed: Mar 20, 2026
1 condition
1 sponsor
2 locations
NCT06644274
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
N/A
Recruiting
40 participants
Started: Oct 20, 2024 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT06662955
Exercise with Audible Cues on Motor Unit Behavior in Athletes with Anterior Cruciate Ligament Reconstruction
NA
Recruiting
40 participants
Started: Oct 20, 2024 · Completed: Dec 30, 2026
3 conditions
1 sponsor
1 location
NCT06288230
An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy
PHASE1/PHASE2
Recruiting
20 participants
Started: Oct 20, 2024 · Completed: Oct 30, 2027
1 condition
1 sponsor
1 location
NCT06603883
Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction
PHASE2/PHASE3
Recruiting
60 participants
Started: Oct 19, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT06458257
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
N/A
Recruiting
50 participants
Started: Oct 19, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06581523
Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners
NA
Recruiting
40 participants
Started: Oct 19, 2024 · Completed: Jul 31, 2025
1 condition
1 sponsor
3 locations
NCT07020637
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
N/A
Recruiting
100 participants
Started: Oct 19, 2024 · Completed: Sep 1, 2026
2 conditions
1 sponsor
1 location
NCT06594263
Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)
N/A
Recruiting
340 participants
Started: Oct 19, 2024 · Completed: Nov 18, 2026
3 conditions
1 sponsor
1 location
NCT06711900
A Study of SKB264 in Combination with Pembrolizumab Versus Chemotherapy in Combination with Pembrolizumab As First-Line Treatment for PD-L1 Negative Patients with Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
PHASE3
Recruiting
432 participants
Started: Oct 19, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05705414
Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
EARLY_PHASE1
Recruiting
28 participants
Started: Oct 18, 2024 · Completed: Mar 31, 2026
1 condition
3 sponsors
1 location
NCT06629610
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
NA
Recruiting
368 participants
Started: Oct 18, 2024 · Completed: Apr 30, 2029
1 condition
6 sponsors
2 locations
NCT06090994
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
PHASE4
Recruiting
756 participants
Started: Oct 18, 2024 · Completed: Nov 30, 2029
1 condition
2 sponsors
9 locations
NCT06507241
Clinical and Instrumental Assessment of Meniscal ROOT Tears Treated Through Suture to the Posterior Cruciate Ligament
N/A
Recruiting
59 participants
Started: Oct 18, 2024 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT06683586
Brazilian Registry of Chronic Venous Disease - Risk Factors, Comorbidities, Clinical and Surgical Treatment
N/A
Recruiting
650 participants
Started: Oct 18, 2024 · Completed: Oct 30, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
336
337
338
339
340
341
342
More pages
1333
Next